Resmed Inc
- Last sale
- Nov 12, 2026 · +0.25%
- Market cap
- $33.64B
- 140.66M shares
- Filings
- 1,070
Q1 2027+9.9% FY26 yoy
Q1 2027+8.8% FY26 yoy
Q1 2027+11.9% FY26 yoy
Q1 2027derived−0.7% FY26 yoy
Q1 2027+9.7% FY26 yoy
Q1 2027+21.5% FY26 yoy
- $33.64B
- 21.1×
- 5.9×
- 5.7×
- 4.78%
- 1.06%
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $5,653,443,000 | reported | |
| FY 2025 | 2025-06-30 | $5,146,327,000 | reported | |
| FY 2024 | 2024-06-30 | $4,685,297,000 | reported | |
| FY 2023 | 2023-06-30 | $4,222,993,000 | reported | |
| FY 2022 | 2022-06-30 | $3,578,127,000 | reported | |
| FY 2021 | 2021-06-30 | $3,196,825,000 | reported | |
| FY 2020 | 2020-06-30 | $2,957,013,000 | reported | |
| FY 2019 | 2019-06-30 | $2,606,572,000 | reported | |
| FY 2018 | 2018-06-30 | $2,340,196,000 | reported | |
| FY 2017 | 2017-06-30 | $2,066,700,000 | reported | |
| FY 2016 | 2016-06-30 | $1,838,713,000 | reported | |
| FY 2015 | 2015-06-30 | $1,678,912,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2026 | $349.66M | $700.04M | $1.05B | $2.40 | 144.25M sh | −1.5% | 63.6% |
| FY2025 | $310.88M | $300.03M | $610.91M | $2.12 | 146.41M sh | −0.4% | 36.8% |
| FY2024 | $282.32M | $150.01M | $432.33M | $1.92 | 146.93M sh | −0.1% | 33.2% |
| FY2023 | $258.28M | $0.00 | $258.28M | $1.76 | 147.07M sh | +0.4% | 45.0% |
| FY2022 | $245.34M | $0.00 | $245.34M | $1.68 | 146.42M sh | +100,410.7% | 113.4% |
Segments
LineFY2026ShareChange
Sleep and Breathing Health$4.98B88%+10.5%
Residential Care Software$675.81M12%+5.4%
Sleep and Respiratory Care———
Sleep and Respiratory Care———
Software As A Service Before Deferred Revenue Adjustment———
Software as a Service———
Software as a Service———
Total$5.65B
Surgical & medical instruments & apparatus
Resmed Inc is the 8th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
BAXBaxter International Inc$11.2B5.7%8.5%$13.3BSOLVSolventum Corp$8.3B0.9%18.7%$15.1B
RMDResmed Inc (this company)$5.7B9.9%26.9%$33.6B
DXCMDexCom Inc$4.7B15.6%17.9%$30.4BMMEDMiniMed Group, Inc.$3.1B14.3%10.7%$5.0BWSTWest Pharmaceutical Services Inc$3.1B6.3%16.1%$28.7BGMEDGlobus Medical Inc$2.9B16.7%18.3%$9.7BPODDInsulet Corp$2.7B30.7%9.1%$9.1BICUIICU Medical Inc$2.2B6.3%0.0%$4.4BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Resmed Inc · CIK 943819 · Engraved from SEC EDGAR